Plus Therapeutics
PSTV
5 hedge funds and large institutions have $552K invested in Plus Therapeutics in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
21% more capital invested
Capital invested by funds: $457K → $552K (+$95K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.4K |
| 2 |
Renaissance Technologies
New York
|
+$5.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$2K |
| 2 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$2 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $257K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $178K | +$5.34K | +8 | +4% |
|
3
Bank of New York Mellon
New York
| $66K | – | – | – |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $32K | +$27.4K | +41 | New |
|
5
Acadian Asset Management
Boston,
Massachusetts
| $19K | – | – | – |
|
|
FP
6
Financial Perspectives
Minneapolis,
Minnesota
| $2 | – | – | – |
|
|
7
Victory Capital Management
San Antonio,
Texas
| – | -$2K | -3 | Closed |
|
|
FDCDDQ
8
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$2 | – | – |
|
PSTV Hedge Fund Activity: Q2 2020 in Review
5 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2020, worth a combined $552K — up 21% from $457K a quarter earlier.
Fund positioning in PSTV was balanced in Q2 2020: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $27.4K. The largest seller was Victory Capital Management, exiting entirely with an estimated $2K sold.
- 5 institutional investors held Plus Therapeutics (PSTV) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $552K of Plus Therapeutics stock for Q2 2020, up 21% quarter-over-quarter.
- 1 fund opened new Plus Therapeutics positions in Q2 2020 and 1 closed out, a net change of 0 holders.
- The largest Plus Therapeutics buyer in Q2 2020 was Vanguard Group, an estimated $27.4K added.
- The largest Plus Therapeutics seller in Q2 2020 was Victory Capital Management, an estimated $2K sold.
Based on aggregated 13F filings for Q2 2020.